COVID-19 Key EU Developments, Policy & Regulatory Update No. 34

Jones Day
Contact

LATEST KEY DEVELOPMENTS

Competition & State Aid

• European Commission prolongs and further expands Temporary Framework to support economy in context of coronavirus outbreak

• EU approves new and amended Member State measures to support the economy

Trade / Export Controls

• European Commission affirms compatibility of COVID-19 export authorization mechanism with international obligations

• European Commission publishes latest list of Member State mechanisms screening foreign direct investments, reflecting various COVID-19 related measures

• Expansion of EU-Japan Economic Partnership Agreement welcomed as instrument to rebuild growth following the COVID-19 pandemic

Medicines, Medical Devices, and Personal Protective Equipment

• EMA starts rolling review of Regeneron/Roche COVID-19 vaccine

• European Commission adopts Implementing Regulation on the authorisation mechanism for exports of COVID-19 vaccines

• EU approves AstraZeneca’s COVID-19 vaccines Cybersecurity, Privacy & Data Protection

• Guidelines on proof of vaccination for medical purposes - basic interoperability elements

Please see full Newsletter elowe for more inforation.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Jones Day | Attorney Advertising

Written by:

Jones Day
Contact
more
less

Jones Day on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.